成都举办CGT全链条主题沙龙 推动细胞与基因治疗产业高质量发展

Core Insights - The event "CGT Drug Development Full Chain" held in Chengdu aims to gather various stakeholders to discuss the innovation pathways in the cell and gene therapy (CGT) industry, contributing to the establishment of Chengdu as a significant biopharmaceutical hub in China [1][2] Group 1: Industry Context - The cell and gene therapy sector is experiencing dual opportunities from technological breakthroughs and policy support, as highlighted in China's "14th Five-Year Plan" for biopharmaceutical development [2] - The salon focuses on key issues across the entire CGT chain, providing a platform for local industry exchange and contributing to the high-quality development of the national CGT industry [2] Group 2: Expert Insights - Experts from various fields shared insights on regulatory review, clinical trial efficiency, commercialization management, international market access strategies, and innovative payment models, identifying pain points and challenges in the industry [3] - The consensus among experts is that achieving synergy across the entire chain from research and development to payment is crucial for the sustainable development of the CGT industry [3] Group 3: Collaborative Efforts - The event facilitated in-depth discussions among industry representatives, researchers, and experts on topics such as CGT technology iteration, clinical translation challenges, cost control, and payment model innovation, reflecting the active collaboration within Chengdu's CGT ecosystem [3] - The salon's comprehensive agenda covering "research-clinical-operation-export-payment" established a multi-perspective dialogue platform, enhancing ecological collaboration and resource integration in Chengdu's CGT industry [3]